- ►annals.org AS Levey, J Coresh, E Balk, AT Kausz, A … - Annals of internal medicine, 2003 - Am Coll Physicians Chronic kidney disease is a worldwide public health problem with an increasing
incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic
kidney disease include not only kidney failure but also complications of ... Cited by 970 - Related articles - BL Direct - All 18 versions
D de Zeeuw, G Remuzzi, HH Parving, WF … - Kidney international, 2004 - nature.com The data from the RENAAL (Reduction in End Points in Noninsulin-Dependent
Diabetes Mellitus with the Angiotensin II Antagonist Losartan) study, a
double-blind, randomized trial, were used to examine the effects of ... Cited by 324 - Related articles - BL Direct - All 5 versions
AM El Nahas, AK Bello - The Lancet, 2005 - Elsevier The worldwide rise in the number of patients with chronic kidney disease (CKD)
and consequent end-stage renal failure necessitating renal replacement therapy
is threatening to reach epidemic proportions over the next decade, and only ... Cited by 224 - Related articles - All 6 versions
RJ Hogg, S Furth, KV Lemley, R Portman, GJ … - Pediatrics, 2003 - pediatrics.org.p.angrylapdog.com Objectives. A series of new guidelines has been developed by the National Kidney
Foundation's Kidney Disease Outcomes Quality Initiative to improve the detection
and management of chronic kidney disease (CKD). In most instances of CKD, ... Cited by 129 - Related articles - BL Direct - All 7 versions
- ►nih.gov G Remuzzi, A Benigni, A Remuzzi - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig The incidence of chronic kidney diseases is increasing worldwide, and these
conditions are emerging as a major public health problem. While genetic factors
contribute to susceptibility and progression of renal disease, proteinuria ... Cited by 118 - Related articles - BL Direct - All 10 versions
M NANGAKU - Internal Medicine, 2004 - J-STAGE There are many different glomerular disorders, in- cluding glomerulonephritis,
diabetic nephropathy, and hypertensive nephrosclerosis. However, once glomerular
damage reaches a certain threshold, the progression of renal disease is ... Cited by 106 - Related articles - BL Direct - All 5 versions
T Li, K Surendran, MA Zawaideh, S Mathew, … - Current opinion in nephrology and hypertension, 2004 - journals.lww.com Purpose of review When last reviewed, bone morphogenetic protein 7 was presented
as a potential new renal therapeutic agent, with multiple efficacies in chronic
kidney disease. The object of this review is to describe progress from many ... Cited by 50 - Related articles - BL Direct - All 9 versions
RN Foley, C Wang, AJ Collins - Mayo Clinic Proceedings, 2005 - mayoclinicproceedings.com Page 1. Mayo Clin Proc. • October 2005;80(10):1270-1277 • www.
mayoclinicproceedings.com 1270 CARDIOVASCULAR RISK AND KIDNEY FUNCTION ... Cited by 52 - Related articles - View as HTML - BL Direct - All 11 versions
- ►asnjournals.org C Chiurchiu, G Remuzzi, P Ruggenenti - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol ESRD represents a major health problem. The number of patients who enter kidney
replacement programs has increased at an average of 7% per year in the past 10
yr. A large number of experimental and clinical studies have demonstrated ... Cited by 34 - Related articles - All 5 versions
